Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M8,112Revenue $M214Net Margin (%)-9.8Altman Z-Score6.8
Enterprise Value $M7,879EPS $-0.3Operating Margin %-11.0Piotroski F-Score4
P/E(ttm)--Beneish M-Score-1.5Pre-tax Margin (%)-15.4Higher ROA y-yY
Price/Book29.310-y EBITDA Growth Rate %--Quick Ratio8.3Cash flow > EarningsY
Price/Sales32.15-y EBITDA Growth Rate %7.4Current Ratio8.3Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-2.8Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-7.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M120ROIC % (ttm)-2,818.4Gross Margin Increase y-yN

Gurus Latest Trades with ISIS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ISISJoel Greenblatt 2015-03-31 Reduce$58.83 - $77.08
($67.85)
$ 67.76-0%Reduce 9.75%7,892
ISISJoel Greenblatt 2014-12-31 Buy $36.46 - $65.09
($49.54)
$ 67.7637%New holding8,745
ISISRon Baron 2014-06-30 Sold Out -0.01%$22.98 - $43.33
($31.44)
$ 67.76116%Sold Out0
ISISGeorge Soros 2014-06-30 Sold Out $22.98 - $43.33
($31.44)
$ 67.76116%Sold Out0
ISISRon Baron 2014-03-31 Buy 0.01%$38.56 - $59
($48.28)
$ 67.7640%New holding45,251
ISISGeorge Soros 2014-03-31 Buy $38.56 - $59
($48.28)
$ 67.7640%New holding5,539
ISISGeorge Soros 2011-06-30 Sold Out $8.54 - $9.38
($8.92)
$ 67.76660%Sold Out0
ISISGeorge Soros 2011-03-31 Buy $8.57 - $10.35
($9.21)
$ 67.76636%New holding22,300
ISISFirst Eagle Investment 2010-12-31 Sold Out -0.01%$8.05 - $10.51
($9.48)
$ 67.76615%Sold Out0
ISISFirst Eagle Investment 2010-09-30 Buy 0.01%$7.775 - $10.07
($8.76)
$ 67.76674%New holding100,000
ISISGeorge Soros 2010-09-30 Sold Out $7.775 - $10.07
($8.76)
$ 67.76674%Sold Out0
ISISGeorge Soros 2010-06-30 Buy $8.84 - $11.13
($9.93)
$ 67.76582%New holding16,100
ISISFirst Eagle Investment 2010-03-31 Sold Out -0.01%$8.66 - $11.76
($10.31)
$ 67.76557%Sold Out0
ISISFirst Eagle Investment 2009-12-31 Buy 0.01%$9.94 - $14.16
($11.94)
$ 67.76468%New holding50,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ISIS is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ISIS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
PARSHALL B LYNNECOO & Secretary 2015-04-07Sell5,565$63.077.44view
CROOKE STANLEY TChairman and CEO 2015-04-07Sell22,377$63.077.44view
PARSHALL B LYNNECOO & Secretary 2015-04-01Sell5,377$61.939.41view
CROOKE STANLEY TChairman and CEO 2015-04-01Sell21,623$61.939.41view
BENNETT C FRANKSVP, Antisense Research 2015-03-24Sell15,000$70.61-4.04view
HOUGEN ELIZABETH LSVP, Finance & CFO 2015-03-19Sell10,000$73.33-7.6view
Geary Richard SSVP, Development 2015-03-19Sell8,000$75-9.65view
O'NEIL PATRICK R.SVP, Legal & General Counsel 2015-03-19Sell30,525$74.85-9.47view
WENDER JOSEPH HDirector 2015-03-18Sell12,500$71.41-5.11view
HOUGEN ELIZABETH LSVP, Finance & CFO 2015-03-05Sell28,094$71.57-5.32view

Press Releases about ISIS :

    Quarterly/Annual Reports about ISIS:

    News about ISIS:

    Articles On GuruFocus.com
    Bayer Enters Into Collaboration With Isis For Enhancing Its Drug Portfolio May 07 2015 
    Analysts Provide Update for Biogen, PTC Therapeutics, GW Pharma, and Isis Pharma Apr 22 2015 
    Value vs. Growth: Is Jim Cramer Right about ISIS Pharmaceuticals? Dec 13 2014 
    Weekly CEO Sells Highlight: Keynote Systems Inc., Isis Pharmaceuticals, Coleman Cable Inc. Jul 01 2013 
    Isis Pharmaceuticals Inc. (ISIS) Director, COO B Lynne Parshall sells 17,200 Shares Dec 29 2010 
    Isis Pharmaceuticals Inc. (ISIS) Chairman, President, CEO Stanley T Crooke sells 32,000 Shares Dec 29 2010 
    Isis Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 05 2010 
    Isis Pharmaceuticals Inc. Reports Operating Results (10-Q) May 07 2010 
    Guru Stocks at 52-Week Low: The Dun & Bradstreet Corp, FTI Consulting Inc, Terra Nitrogen Company L. Mar 07 2010 
    Guru Stocks at 52-Week Low: Dun & Bradstreet Corp, GameStop Corp, Dean Foods Company, SunPower Corp, Feb 21 2010 

    More From Other Websites
    Is the Stock Market Due for a Correction? May 18 2015
    ISIS PHARMACEUTICALS INC Financials May 13 2015
    4 Biotech Stocks Could Have Big Upside Before Russell Index Changes May 12 2015
    10-Q for Isis Pharmaceuticals, Inc. May 07 2015
    Another Goliath Partners With Isis Pharmaceuticals May 06 2015
    Is Isis just what the doctor ordered? May 06 2015
    Isis Pharmaceuticals' Q1 Loss Narrower than Expected - Analyst Blog May 06 2015
    Isis Pharmaceuticals (ISIS) Earnings Report: Q1 2015 Conference Call Transcript May 06 2015
    Isis Reports Financial Results and Highlights for First Quarter 2015 May 05 2015
    ISIS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... May 05 2015
    Isis reports 1Q loss May 05 2015
    Isis reports 1Q loss May 05 2015
    Isis Reports Financial Results and Highlights for First Quarter 2015 May 05 2015
    Isis Pharmaceuticals (ISIS) Stock Rises After CEO Appears on Jim Cramer's 'Mad Money' May 05 2015
    Q1 2015 Isis Pharmaceuticals Inc Earnings Release - Before Market Open May 05 2015
    Jim Cramer's Top Takeaways: Dow Chemical, Isis Pharmaceuticals, Wells Fargo May 05 2015
    Jim Cramer's 'Mad Money' Recap: Buffett 'Halo,' Dollar Top, Growth Stocks Spurred Rally May 04 2015
    Will Isis Pharmaceuticals (ISIS) Disappoint in Q1 Earnings? - Analyst Blog May 04 2015
    Isis Pharma Up As Bayer Licenses Thrombosis Drug May 04 2015
    ISIS Pharmaceuticals Cuts License Deal With Bayer AG May 04 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK